|
At the time of this report, mentor has received no information regarding explantation or an expected explantation date. it is unknown at this time if the device will be made available for return. as a result, no product failure analysis can be conducted, and no determination of possible contributing factors can be made. as such, the investigation will be closed. if the complaint device is received in the future, the investigation will be reopened and conducted as appropriate.A manufacturing record evaluation (mre) was performed, and no anomalies were found related to this complaint.In addition, the mre verifies that the device was manufactured in accordance with documented specification and procedures.Mentor is submitting this report pursuant to the provisions of 21 cfr, part 803. this report may be based on information which mentor has not been able to investigate or verify prior to the required reporting date. this report does not reflect a conclusion by fda, mentor, or its employees that the report constitutes an admission that the device, mentor, or its employees caused or contributed to the potential event described in this report. if certain information is unknown, not available or does not apply, the section/field of the form is left blank.Reason for device explant and/or reoperation: breast cyst manufacturer¿s reference number: (b)(4).
|
|
It was reported that a caucasian female patient, involved in a clinical trial, underwent a primary breast augmentation surgery with implantation of a 600cc mentor memorygel breast implant prosthesis.Post-operatively, the patient was diagnosed with bilateral breast masses/cysts.As a result, the patient underwent surgical intervention to remove the masses/cysts.There were no reported manipulations to the breast implants.This report is for the left breast prosthesis.Refer to manufacturing report number 1645337-2022-00616 for the contralateral event.
|